title: Long pulse 532-nm laser treatment of facial telangiectasia.
abstract: BACKGROUND
  Facial telangiectasias are a frequently observed cosmetic concern: Current therapeutic modalities have certain side effects and limitations. We treated a group of patients with facial telangiectasias with a new variable pulse width frequency-doubled neodymium: YAG laser at 532 nm.
  
  
  OBJECTIVE
  This study evaluated the clinical response and side effects during the treatment of facial telangiectasias in 40 patients.
  
  
  METHODS
  Forty patients with facial telangiectasias were treated with the VersaPulse laser. Fluences of between 9.5 and 12.0 J/cm2 at 3 or 4-mm spot size were used. A sapphire water-cooled chill tip was used to cool the cutaneous surface during treatment.
  
  
  RESULTS
  Ninety percent of patients experienced between 75% and 100% clearance of their facial telangiectasias after single treatment. No significant side effects or complications were noted.
  
  
  CONCLUSIONS
  The VersaPulse variable pulse width neodymium: YAG laser appears to be an effective treatment modality for facial telangiectasia.
authors.affiliation: Department of Pediatrics, Georgetown University Medical School, Washington, DC, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Adrian
authors.forename: E A
authors.initials: EA
authors.lastname: Tanghetti
mesh_terms: D005145:Face / Q000601:surgery*; D006801:Humans; D053685:Laser Therapy; D012867:Skin / Q000473:pathology; D013684:Telangiectasis / Q000473:pathology / Q000601:surgery*